The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive analysis of the mutational status of early colon cancer: Real world data from the AIO ColoPredict registry study.
 
Doreen Maria Gisder
No Relationships to Disclose
 
Sarah Wisser
No Relationships to Disclose
 
Celine Lugnier
No Relationships to Disclose
 
Jens Christmann
Honoraria - AstraZeneca; Janssen-Cilag GmbH Germany; Qiagen
Consulting or Advisory Role - AstraZeneca
 
Kraeft Anna-Lena
No Relationships to Disclose
 
Inke Sabine Feder
No Relationships to Disclose
 
Iris Tischoff
No Relationships to Disclose
 
Christian Teschendorf
No Relationships to Disclose
 
Heuer Vera
No Relationships to Disclose
 
Bülent Sargin
No Relationships to Disclose
 
Stepahn Hollerbach
No Relationships to Disclose
 
Christof Lamberti
No Relationships to Disclose
 
Andrea Tannapfel
No Relationships to Disclose
 
Anke C. Reinacher-Schick
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; MCI Group; Merck Serono; MSD; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD; Pierre Fabre; Roche
Research Funding - AIO-Studien (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); AstraZeneca (Inst); BioNTech (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Ipsen (Inst); Lilly (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Pierre Fabre; Pierre Fabre; Roche